News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
683,364 Results
Type
Article (38969)
Company Profile (276)
Press Release (644119)
Section
Business (203824)
Career Advice (1985)
Deals (35357)
Drug Delivery (84)
Drug Development (80770)
Employer Resources (168)
FDA (16085)
Job Trends (14797)
News (344466)
Policy (32429)
Tag
Academia (2530)
Alliances (49035)
Alzheimer's disease (1215)
Approvals (16004)
Artificial intelligence (116)
Bankruptcy (352)
Best Places to Work (11465)
Biotechnology (196)
Breast cancer (108)
Cancer (906)
Cardiovascular disease (81)
Career advice (1656)
Cell therapy (200)
Clinical research (63927)
Collaboration (326)
Compensation (168)
COVID-19 (2522)
Cystic fibrosis (78)
Data (862)
Diabetes (134)
Diagnostics (6097)
Earnings (84171)
Employer resources (146)
Events (108898)
Executive appointments (248)
FDA (16530)
Funding (291)
Gene therapy (149)
GLP-1 (558)
Government (4318)
Healthcare (18654)
Infectious disease (2597)
Inflammatory bowel disease (102)
Interviews (308)
IPO (16271)
Job creations (3622)
Job search strategy (1415)
Layoffs (408)
Legal (7848)
Lung cancer (155)
Manufacturing (151)
Medical device (13148)
Medtech (13153)
Mergers & acquisitions (19108)
Metabolic disorders (364)
Neuroscience (1456)
NextGen Class of 2024 (6496)
Non-profit (4462)
Northern California (1212)
Obesity (216)
Opinion (176)
Patents (94)
People (56129)
Phase I (19828)
Phase II (28147)
Phase III (21015)
Pipeline (212)
Postmarket research (2553)
Preclinical (8430)
Radiopharmaceuticals (234)
Rare diseases (180)
Real estate (5888)
Regulatory (21441)
Research institute (2307)
Resumes & cover letters (349)
Southern California (1085)
Startups (3560)
United States (11709)
Vaccines (537)
Weight loss (160)
Date
Today (288)
Last 7 days (846)
Last 30 days (2972)
Last 365 days (35701)
2024 (30469)
2023 (40074)
2022 (51173)
2021 (55713)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31481)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (187)
Asia (37012)
Australia (6037)
California (2741)
Canada (1180)
China (209)
Colorado (119)
Connecticut (123)
Europe (79243)
Florida (396)
Georgia (100)
Illinois (308)
Indiana (179)
Kansas (95)
Maryland (516)
Massachusetts (2248)
Michigan (143)
Minnesota (250)
New Jersey (829)
New York (842)
North Carolina (665)
Northern California (1212)
Ohio (127)
Pennsylvania (748)
South America (1091)
Southern California (1085)
Texas (385)
Utah (80)
Washington State (323)
683,364 Results for "cvrx inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
CVRx Announces Appointment of Robert Allen John as Chief Revenue Officer
CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, today announced the appointment of Robert John as Chief Revenue Officer effective June 27.
June 25, 2024
·
2 min read
Business
CVRx Announces Key Senior Leadership Team Hires
CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership team.
May 16, 2024
·
4 min read
Business
CVRx Reports First Quarter 2024 Financial and Operating Results
CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results for the first quarter of 2024.
April 30, 2024
·
10 min read
Press Releases
CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025
November 5, 2024
·
3 min read
Press Releases
CVRx Reports Third Quarter 2024 Financial and Operating Results
October 29, 2024
·
13 min read
Press Releases
CVRx announces new CPT® Category I codes for Barostim
October 21, 2024
·
3 min read
Business
CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024
CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative extravascular implantable neuromodulation device for patients with cardiovascular diseases, today announced that it plans to release first quarter 2024 financial and operating results after market close on Tuesday, April 30th, 2024.
April 16, 2024
·
1 min read
BioMidwest
CVRx announces availability of additional data supporting long-term benefits of Barostim
CVRx, Inc., a commercial-stage medical device company, announced the availability of additional data, including the publication of results of the post-market phase of the BeAT-HF trial in the European Journal of Heart Failure.
April 15, 2024
·
3 min read
Press Releases
CVRx Announces Increased Inpatient Payment for Barostim Procedure
August 2, 2024
·
1 min read
Business
CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer
CVRx, Inc . (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today the appointment of Kevin Hykes as the Company’s new President and Chief Executive Officer, effective February 12. Hykes will continue to serve on the Company’s Board.
January 31, 2024
·
4 min read
1 of 68,337
Next
